Single-dose Escalation Study of SQ-001 Infusion to Characterize the PK Profiles of Major Sentinel Compounds in Healthy Adult Volunteers in US
Clinical trial NCT04026321 · COMPLETED
Trial details
- NCT number
- NCT04026321
- Sponsor
- Livzon Pharmaceutical Group Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-03
- Primary completion
- 2018-12-06
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.